Focusing on Referral Rather than Selection for Advanced Heart Failure Therapies

by Tonje Thorvaldsen, Lars H Lund
Published 2019-01-01

Mechanistic and Therapeutic Implications of Extracellular Vesicles as a Potential Link Between Covid-19 and Cardiovascular Disease Manifestations

by Gianluigi Pironti, Daniel C. Andersson, Daniel C. Andersson, Lars H. Lund, Lars H. Lund
Published 2021-02-01

Congestion and Diuretic Resistance in Acute or Worsening Heart Failure

by Ingibjörg Kristjánsdóttir, Tonje Thorvaldsen, Lars H Lund
Published 2020-09-01

Critical appraisal of the instantaneous end‐diastolic pulmonary arterial wedge pressures

by Aristomenis Manouras, Lars H. Lund, László Gellér, Anikó Ilona Nagy, Jonas Johnson
Published 2020-12-01

Limited value of NT-proBNP as a prognostic marker of all-cause mortality in patients with heart failure with preserved and mid-range ejection fraction in primary care: A report fro...

by Björn Eriksson, Per Wändell, Ulf Dahlström, Per Näsman, Lars H. Lund, Magnus Edner
Published 2019-11-01

The Swedish Heart Failure Registry: a living, ongoing quality assurance and research in heart failure

by Gianluigi Savarese, Peter Vasko, Åsa Jonsson, Magnus Edner, Ulf Dahlström, Lars H. Lund
Published 2019-01-01

Prognostic impact of Framingham heart failure criteria in heart failure with preserved ejection fraction

by Ulrika Löfström, Camilla Hage, Gianluigi Savarese, Erwan Donal, Jean‐Claude Daubert, Lars H. Lund, Cecilia Linde
Published 2019-08-01

Non‐insulin antihyperglycaemic drugs and heart failure: an overview of current evidence from randomized controlled trials

by Gianluigi Savarese, Benedikt Schrage, Francesco Cosentino, Lars H. Lund, Giuseppe M.C. Rosano, Petar Seferovic, Javed Butler
Published 2020-12-01

Controller and battery changes due to technical problems related to the HVAD® left ventricular assist device - a single center experience

by Emil Najjar, Ann Hallberg Kristensen, Tonje Thorvaldsen, Laila Hubbert, Peter Svenarud, Magnus Dalén, Agneta Månsson Broberg, Lars H. Lund
Published 2018-06-01

Validation of non‐invasive ramp testing for HeartMate 3

by Emil Najjar, Tonje Thorvaldsen, Magnus Dalén, Peter Svenarud, Ann Hallberg Kristensen, Maria J. Eriksson, Eva Maret, Lars H. Lund
Published 2020-04-01

Circulating neuregulin1‐β in heart failure with preserved and reduced left ventricular ejection fraction

by Camilla Hage, Eva Wärdell, Cecilia Linde, Erwan Donal, Carolyn S.P. Lam, Claude Daubert, Lars H. Lund, Agneta Månsson‐Broberg
Published 2020-04-01

Predictors of long‐term outcome in heart failure with preserved ejection fraction: a follow‐up from the KaRen study

by Angiza Shahim, Marion Hourqueig, Erwan Donal, Emmanuel Oger, Ashwin Venkateshvaran, Jean‐Claude Daubert, Gianluigi Savarese, Cecilia Linde, Lars H. Lund, Camilla Hage
Published 2021-10-01

Myeloperoxidase and related biomarkers are suggestive footprints of endothelial microvascular inflammation in HFpEF patients

by Camilla Hage, Erik Michaëlsson, Bengt Kull, Tasso Miliotis, Sara Svedlund, Cecilia Linde, Erwan Donal, Jean‐Claude Daubert, Li‐Ming Gan, Lars H. Lund
Published 2020-08-01

Implementation of sacubitril/valsartan in Sweden: clinical characteristics, titration patterns, and determinants

by Michael Fu, Ola Vedin, Bodil Svennblad, Erik Lampa, Daniel Johansson, Ulf Dahlström, Krister Lindmark, Peter Vasko, Anna Lundberg, Madlaina Costa‐Scharplatz, Lars H. Lund
Published 2020-12-01

Management of heart failure with reduced ejection fraction in Europe: design of the ARIADNE registry

by Uwe Zeymer, Andrew L. Clark, Vivencio Barrios, Thibaud Damy, Jaroslaw Drożdż, Candida Fonseca, Lars H. Lund, Gabriele Di Comite, Stephan Hupfer, Aldo P. Maggioni
Published 2020-04-01

A registry‐based algorithm to predict ejection fraction in patients with heart failure

by Alicia Uijl, Lars H. Lund, Ilonca Vaartjes, Jasper J. Brugts, Gerard C. Linssen, Folkert W. Asselbergs, Arno W. Hoes, Ulf Dahlström, Stefan Koudstaal, Gianluigi Savarese
Published 2020-10-01

Electrostatic Discharge Causing Pump Shutdown in HeartMate 3

by Emil Najjar, MD, PhD, Ann Hallberg Kristensen, Tonje Thorvaldsen, MD, PhD, Magnus Dalén, MD, PhD, Ulrich P. Jorde, MD, PhD, Lars H. Lund, MD, PhD
Published 2021-03-01

Risk stratification with echocardiographic biomarkers in heart failure with preserved ejection fraction: the media echo score

by Olivier Huttin, Alan G. Fraser, Lars H. Lund, Erwan Donal, Cecilia Linde, Masatake Kobayashi, Tamas Erdei, Jean‐Loup Machu, Kevin Duarte, Patrick Rossignol, Walter Paulus, Faiez Zannad, Nicolas Girerd, MEDIA and KaRen investigators
Published 2021-06-01

Disproportionate left atrial myopathy in heart failure with preserved ejection fraction among participants of the PROMIS-HFpEF study

by Ravi B. Patel, Carolyn S. P. Lam, Sara Svedlund, Antti Saraste, Camilla Hage, Ru-San Tan, Lauren Beussink-Nelson, Jasper Tromp, Cynthia Sanchez, Joyce Njoroge, Stanley A. Swat, Ulrika Ljung Faxén, Maria Lagerstrom Fermer, Ashwin Venkateshvaran, Li-Ming Gan, Lars H. Lund, Sanjiv J. Shah
Published 2021-03-01

Is heart failure misdiagnosed in hospitalized patients with preserved ejection fraction? From the European Society of Cardiology ‐ Heart Failure Association EURObservational Resear...

by Agnieszka Kapłon‐Cieślicka, Cécile Laroche, Maria G. Crespo‐Leiro, Andrew J.S. Coats, Stefan D. Anker, Gerasimos Filippatos, Aldo P. Maggioni, Camilla Hage, Antonio Lara‐Padrón, Alessandro Fucili, Jarosław Drożdż, Petar Seferovic, Giuseppe M.C. Rosano, Alexandre Mebazaa, Theresa McDonagh, Mitja Lainscak, Frank Ruschitzka, Lars H. Lund, Heart Failure Association (HFA) of the European Society of Cardiology (ESC) and the ESC Heart Failure Long‐Term Registry Investigators
Published 2020-10-01